Dr. Singh, a clinical researcher, is conducting a study wherein some patients receive a drug and others receive a placebo. If this researcher and study are typical, what does Dr. Singh want to find out from the research?
A) Whether the drug works better than the placebo
B) Whether the placebo has any effectiveness at all
C) Whether the placebo works better than the drug
D) Whether the drug and placebo work equally well
Question 2
Dr. Jonas is conducting a single-blind experimental study with human participants to investigate a medical procedure's effectiveness. What is true about this research?
A) Dr. Jonas can control for participant expectancy more than in a double-blind design.
B) Dr. Jonas cannot control for participant expectancy as well as in double-blind designs.
C) Dr. Jonas will need to establish the same expectancies for all the participants for control.
D) Dr. Jonas is using a research design that informs participants which treatment they receive.
Patients are encouraged to take an active role in their health care.
Clinically Significant Drug-Food Interactions in Dentistry
Insurgencies and Drug Trafficking
Drug Approval Stages
The Drug Development Process
Opener A researcher examines an agarose gel